Cibus, Inc. (NASDAQ:CBUS) CFO Carlo Broos Sells 4,647 Shares

Cibus, Inc. (NASDAQ:CBUS) CFO Carlo Broos sold 4,647 shares of the company’s stock in a transaction dated Tuesday, November 12th. The shares were sold at an average price of $5.30, for a total transaction of $24,629.10. Following the completion of the transaction, the chief financial officer now directly owns 74,197 shares in the company, valued at $393,244.10. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website.

Cibus Price Performance

CBUS stock traded down $0.36 during mid-day trading on Wednesday, reaching $4.95. The company had a trading volume of 106,565 shares, compared to its average volume of 137,380. The firm has a fifty day simple moving average of $4.06 and a 200 day simple moving average of $8.68. Cibus, Inc. has a fifty-two week low of $2.86 and a fifty-two week high of $23.18.

Wall Street Analyst Weigh In

A number of research firms recently weighed in on CBUS. Alliance Global Partners lowered their price objective on shares of Cibus from $25.00 to $23.50 and set a “buy” rating for the company in a research report on Tuesday, September 24th. Canaccord Genuity Group reiterated a “buy” rating and issued a $20.00 price objective on shares of Cibus in a report on Tuesday, October 22nd. HC Wainwright reaffirmed a “buy” rating and issued a $25.00 target price on shares of Cibus in a research report on Monday. Finally, Canaccord Genuity Group raised shares of Cibus to a “strong-buy” rating in a research note on Friday, July 19th.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Armistice Capital LLC purchased a new position in Cibus in the second quarter valued at $5,083,000. Vanguard Group Inc. boosted its holdings in Cibus by 3.7% in the first quarter. Vanguard Group Inc. now owns 721,945 shares of the company’s stock valued at $16,215,000 after purchasing an additional 26,017 shares in the last quarter. Rhumbline Advisers purchased a new position in Cibus in the second quarter valued at approximately $221,000. FineMark National Bank & Trust lifted its position in shares of Cibus by 24.3% during the 2nd quarter. FineMark National Bank & Trust now owns 20,488 shares of the company’s stock worth $202,000 after buying an additional 4,000 shares during the last quarter. Finally, Bank of New York Mellon Corp acquired a new position in shares of Cibus in the 2nd quarter valued at $529,000. Institutional investors and hedge funds own 33.81% of the company’s stock.

Cibus Company Profile

Cibus, Inc, a agricultural biotechnology company, develops and licenses plant traits to seed companies for royalties. The company primarily focus on trait productivity in two areas, including productivity traits that enable farmers to have higher yields and reduce the use of the crop protection chemicals and fertilizers; and sustainable ingredients that enable corporations to replace ingredients that are fossil fuel based or whose production results in increased greenhouse gases.